Endocare Inc.
The Irvine medical device and technology company reported a net loss of $2.6 million, or 24 cents a share, for the second quarter, compared with a net loss of $1.2 million, or 12 cents a share, a year ago. Revenue declined 26% to $606,510.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
